The aim of this study was to explore the in vivo effect of Zol on circulating VEGF levels and the possible role for vitamin D on the Zol mediated VEGF perturbancies in a cohort of postmenopausal women treated for osteoporosis. This evidence concerns the gene VEGFA and osteoporosis.